Literature DB >> 20610718

Equus caballus major histocompatibility complex class I is an entry receptor for equine herpesvirus type 1.

Brian M Kurtz1, Lauren B Singletary, Sean D Kelly, Arthur R Frampton.   

Abstract

In this study, Equus caballus major histocompatibility complex class I (MHC-I) was identified as a cellular entry receptor for the alphaherpesvirus equine herpesvirus type 1 (EHV-1). This novel EHV-1 receptor was discovered using a cDNA library from equine macrophages. cDNAs from this EHV-1-susceptible cell type were inserted into EHV-1-resistant B78H1 murine melanoma cells, these cells were infected with an EHV-1 lacZ reporter virus, and cells that supported virus infection were identified by X-Gal (5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside) staining. Positive cells were subjected to several rounds of purification to obtain homogeneous cell populations that were shown to be uniformly infected with EHV-1. cDNAs from these cell populations were amplified by PCR and then sequenced. The sequence data revealed that the EHV-1-susceptible cells had acquired an E. caballus MHC-I cDNA. Cell surface expression of this receptor was verified by confocal immunofluorescence microscopy. The MHC-I cDNA was cloned into a mammalian expression vector, and stable B78H1 cell lines were generated that express this receptor. These cell lines were susceptible to EHV-1 infection while the parental B78H1 cells remained resistant to infection. In addition, EHV-1 infection of the B78H1 MHC-I-expressing cell lines was inhibited in a dose-dependent manner by an anti-MHC-I antibody.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20610718      PMCID: PMC2937649          DOI: 10.1128/JVI.00287-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Equine herpesvirus 1 enters cells by two different pathways, and infection requires the activation of the cellular kinase ROCK1.

Authors:  Arthur R Frampton; Donna B Stolz; Hiroaki Uchida; William F Goins; Justus B Cohen; Joseph C Glorioso
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

2.  Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing.

Authors:  Danijela Koppers-Lalic; Eric A J Reits; Maaike E Ressing; Andrea D Lipinska; Rupert Abele; Joachim Koch; Marisa Marcondes Rezende; Pieter Admiraal; Daphne van Leeuwen; Krystyna Bienkowska-Szewczyk; Thomas C Mettenleiter; Frans A M Rijsewijk; Robert Tampé; Jacques Neefjes; Emmanuel J H J Wiertz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-25       Impact factor: 11.205

Review 3.  Traffic of proteins and peptides across membranes for immunosurveillance by CD8(+) T lymphocytes: a topological challenge.

Authors:  Carolina Johnstone; Margarita Del Val
Journal:  Traffic       Date:  2007-09-06       Impact factor: 6.215

Review 4.  Pathogen evasion strategies for the major histocompatibility complex class I assembly pathway.

Authors:  Antony N Antoniou; Simon J Powis
Journal:  Immunology       Date:  2008-02-18       Impact factor: 7.397

Review 5.  Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases.

Authors:  Paul J Lehner; Simon Hoer; Roger Dodd; Lidia M Duncan
Journal:  Immunol Rev       Date:  2005-10       Impact factor: 12.988

6.  Potential of equine herpesvirus 1 as a vector for immunization.

Authors:  Sascha Trapp; Jens von Einem; Helga Hofmann; Josef Köstler; Jens Wild; Ralf Wagner; Martin Beer; Nikolaus Osterrieder
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

7.  Equine herpesvirus 1 entry via endocytosis is facilitated by alphaV integrins and an RSD motif in glycoprotein D.

Authors:  Gerlinde R Van de Walle; Sarah T Peters; Brian C VanderVen; Dennis J O'Callaghan; Nikolaus Osterrieder
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

8.  Equine herpesvirus type 1 (EHV-1) utilizes microtubules, dynein, and ROCK1 to productively infect cells.

Authors:  Arthur R Frampton; Hiroaki Uchida; Jens von Einem; William F Goins; Paola Grandi; Justus B Cohen; Nikolaus Osterrieder; Joseph C Glorioso
Journal:  Vet Microbiol       Date:  2009-08-08       Impact factor: 3.293

Review 9.  Immune escape of equine herpesvirus 1 and other herpesviruses of veterinary importance.

Authors:  Karen M van der Meulen; Herman W Favoreel; Maurice B Pensaert; Hans J Nauwynck
Journal:  Vet Immunol Immunopathol       Date:  2006-02-10       Impact factor: 2.046

10.  Varicellovirus UL 49.5 proteins differentially affect the function of the transporter associated with antigen processing, TAP.

Authors:  Danijela Koppers-Lalic; Marieke C Verweij; Andrea D Lipińska; Ying Wang; Edwin Quinten; Eric A Reits; Joachim Koch; Sandra Loch; Marisa Marcondes Rezende; Franz Daus; Krystyna Bieńkowska-Szewczyk; Nikolaus Osterrieder; Thomas C Mettenleiter; Mirjam H M Heemskerk; Robert Tampé; Jacques J Neefjes; Shafiqul I Chowdhury; Maaike E Ressing; Frans A M Rijsewijk; Emmanuel J H J Wiertz
Journal:  PLoS Pathog       Date:  2008-05-30       Impact factor: 6.823

View more
  14 in total

1.  Single amino acid residue in the A2 domain of major histocompatibility complex class I is involved in the efficiency of equine herpesvirus-1 entry.

Authors:  Michihito Sasaki; Eunmi Kim; Manabu Igarashi; Kimihito Ito; Rie Hasebe; Hideto Fukushi; Hirofumi Sawa; Takashi Kimura
Journal:  J Biol Chem       Date:  2011-09-26       Impact factor: 5.157

2.  Equine herpesvirus type 4 UL56 and UL49.5 proteins downregulate cell surface major histocompatibility complex class I expression independently of each other.

Authors:  Abdelrahman Said; Walid Azab; Armando Damiani; Nikolaus Osterrieder
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

3.  Equine herpesvirus type 1-mediated oncolysis of human glioblastoma multiforme cells.

Authors:  Michael J Courchesne; Maria C White; Brent A Stanfield; Arthur R Frampton
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

4.  Glycoproteins D of equine herpesvirus type 1 (EHV-1) and EHV-4 determine cellular tropism independently of integrins.

Authors:  Walid Azab; Nikolaus Osterrieder
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

5.  Glycoprotein H and α4β1 integrins determine the entry pathway of alphaherpesviruses.

Authors:  Walid Azab; Maik J Lehmann; Nikolaus Osterrieder
Journal:  J Virol       Date:  2013-03-20       Impact factor: 5.103

6.  Equine major histocompatibility complex class I molecules act as entry receptors that bind to equine herpesvirus-1 glycoprotein D.

Authors:  Michihito Sasaki; Rie Hasebe; Yoshinori Makino; Tadaki Suzuki; Hideto Fukushi; Minoru Okamoto; Kazuya Matsuda; Hiroyuki Taniyama; Hirofumi Sawa; Takashi Kimura
Journal:  Genes Cells       Date:  2011-02-10       Impact factor: 1.891

7.  Differential MHC class I expression in distinct leukocyte subsets.

Authors:  Justin M Greene; Roger W Wiseman; Simon M Lank; Benjamin N Bimber; Julie A Karl; Benjamin J Burwitz; Jennifer J Lhost; Oriana E Hawkins; Kevin J Kunstman; Karl W Broman; Steven M Wolinsky; William H Hildebrand; David H O'Connor
Journal:  BMC Immunol       Date:  2011-07-15       Impact factor: 3.615

8.  Equid herpesvirus type 1 activates platelets.

Authors:  Tracy Stokol; Wee Ming Yeo; Deborah Burnett; Nicole DeAngelis; Teng Huang; Nikolaus Osterrieder; James Catalfamo
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

9.  Binding of alphaherpesvirus glycoprotein H to surface α4β1-integrins activates calcium-signaling pathways and induces phosphatidylserine exposure on the plasma membrane.

Authors:  Walid Azab; Andrea Gramatica; Andreas Herrmann; Nikolaus Osterrieder
Journal:  mBio       Date:  2015-10-20       Impact factor: 7.867

10.  The role of glycoprotein H of equine herpesviruses 1 and 4 (EHV-1 and EHV-4) in cellular host range and integrin binding.

Authors:  Walid Azab; Lara Zajic; Nikolaus Osterrieder
Journal:  Vet Res       Date:  2012-08-21       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.